Montréal at the forefront of oncology research and cancer treatment

published on July 20, 2017
What's New in Montréal

A disease that knows no borders, cancer is a universal concern. And from early prognosis to new technological advancements, Montréal is playing a major role in the global fight against cancer. In addition ground-breaking work in the fields of Cardiology and Neuroscience, the city’s dedicated Oncology sector is another world leader in the research and development of cancer treatments and the quest for cures.


Ranked internationally as the Best City for Students in 2017, Montréal’s universities offer specialized focus on cancer studies in coordination with some of the world’s finest on-campus medical research centres. Students work alongside medical researchers and patients in a united fight towards a cure in both English and French, and their findings have played a major role in the way we combat cancer.

McGill University

Ranked as one of the world’s finest educational institutions, McGill University’s Life Sciences Complex is a leader in cancer studies and development, with the Rosalind and Morris Goodman Cancer Centre dedicated full-time to specialized study on the disease. The internationally celebrated Montréal Neurological Institute and Hospital (NEURO) has also just announced a hand-held probe capable of detecting cancer tumour cells, in the process changing the face of cancer-related surgery, marking McGill as a vital voice in cancer studies.

University of Montréal

Home to scientists such as Alain Verreault – the Canadian Research Chair in Nucleosome Assembly and Genome Integrity, focused on improving chemotherapy treatment – the University of Montréal includes several important cancer-related faculties. The Institute for Research in Immunology and Cancer (IRIC) is responsible for several major discoveries in cancer research, and the University also hosts the Scotia Bank Chair in Breast Cancer Diagnosis and Treatment and the CIBC Chair in Causes of Breast Cancer.

Reaching into the community, the Guy-Bernier Research Center at Maisonneuve-Rosemont Hospital(CRHMR) and the Research Center of the Sainte-Justine University Hospital (CHUSJ) both offer multi-disciplinary study and research into cancer behaviours and potential solutions.


The BioMed research centre focuses on prevention and treatment, working in close proximity with several institutions around the world.


Montréal’s medical community has been on the forefront of a number of major breakthroughs in cancer research. Here are just a few.


April 4, 2017 | IRICoR and C3i Announce Partnership to Identify novel Tumor-Specific Antigens (TSAs)

The Institute for Research in Immunology and Cancer – Commercialization of Research (IRICoR) and the Centre for Commercialization of Cancer Immunotherapy (C3i) announced a major collaboration to identify novel tumour specific antigens (TSAs), building upon techniques developed by Dr. Claude Perreault and colleagues at the Institute for Research in Immunology and Cancer (IRIC) at the Université de Montréal, under the leadership of haematologist Dr. Lambert Busque.


March 3, 2017 | Montréal Nanorobotics Laboratory wins the 2016 Québec Science Discovery of the Year People’s Choice award

Professor Sylvain Martel, Director of the Polytechnique Montréal Nanorobotics Laboratory, and a team of researchers from Polytechnique Montréal, Université de Montréal and McGill University achieved a major leap forward in cancer research by developing new nanorobotic agents able to navigate through the bloodstream to administer a drug with precision without the usual side effects of chemotherapy.


2013-2017 | Project to develop personalized cancer immunotherapy

Starting in 2013, Dr. Claude Perreault and Dr. Denis-Claude Roy have made developments in immunotherapy that have the potential to add countless years to the lives of cancer patients and eliminate an estimated $1.6 billion in cancer-related spending.


November 2015 | Intelligent gel attacks cancer

Montréal researchers have introduced a new injectable “biogel” that is effective in delivering anti-cancer agents directly into cancerous tumours and killing them. The recipe for this promising biogel was developed by Sophie Lerouge, a researcher at the CRCHUM and professor in the Department of Mechanical Engineering at the École de technologie supérieure. Biogel allows doctors to focus on localized cancer treatments over full-body treatments, which can be more harmful on a patient’s overall well-being.